Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell

P Reddy1, K Johnson, J P Uberti

  • 1Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Department of Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. reddypr@umich.edu

Insights

Chronic graft-versus-host disease (cGVHD), a complication of hematopoietic cell transplantation (HCT), can affect the kidneys, causing nephrotic syndrome (NS). This study highlights membranous nephropathy as a key finding and suggests antibody-mediated damage treatment for cGVHD-related NS.

Area of Science:

  • Nephrology
  • Hematology
  • Immunology

Background:

  • Chronic graft-versus-host disease (cGVHD) is a frequent complication after allogeneic hematopoietic cell transplantation (HCT), leading to significant patient morbidity and mortality.
  • While kidneys are not typically considered a target organ for cGVHD in humans, animal models suggest renal damage.
  • Renal involvement manifesting as nephrotic syndrome (NS) in cGVHD patients is rarely documented.

Purpose of the Study:

  • To report the largest series to date of patients with nephrotic syndrome (NS) associated with chronic graft-versus-host disease (cGVHD).
  • To describe the clinicopathologic features and clinical course of NS in the context of cGVHD.
  • To explore potential immunopathologic mechanisms and therapeutic strategies for cGVHD-associated NS.

Main Methods:

  • Retrospective case series analysis of nine patients with NS and cGVHD.
  • Review of clinical data, including transplantation history and cGVHD status.
  • Analysis of renal biopsy pathology, predominantly focusing on membranous nephropathy.
  • Correlation of NS clinical course with cGVHD activity.

Main Results:

  • Nine patients with NS associated with cGVHD were identified, including two who received reduced-intensity conditioning regimens.
  • Membranous nephropathy was the predominant pathological finding on renal biopsy.
  • The clinical course of NS was temporally linked to cGVHD features in most cases.
  • Clinicopathologic findings suggest an antibody-mediated immunopathologic process.

Conclusions:

  • Nephrotic syndrome can occur in patients with chronic graft-versus-host disease, with membranous nephropathy being a common pathological finding.
  • The immunopathologic features of NS in this context are consistent with antibody-mediated damage.
  • Therapies targeting antibody-mediated damage, such as anti-B-cell antibodies, may be beneficial for managing cGVHD-associated NS.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...